Filing Details

Accession Number:
0001209191-10-000257
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-01-04 12:00:00
Reporting Period:
2009-12-31
Filing Date:
2010-01-04
Accepted Time:
2010-01-04 16:11:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1333248 Cadence Pharmaceuticals Inc CADX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1378690 R Theodore Schroeder C/O Cadence Pharmaceuticals, Inc.
12481 High Bluff Drive, Suite 200
San Diego CA 92130
President, Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2009-12-31 19,657 $9.76 471,343 No 4 S Indirect By the Schroeder Living Trust
Common Stock Disposition 2010-01-04 10,343 $9.80 461,000 No 4 S Indirect By the Schroeder Living Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By the Schroeder Living Trust
No 4 S Indirect By the Schroeder Living Trust
Footnotes
  1. The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 16, 2009.
  2. This transaction was executed in multiple trades at prices ranging from a low of $9.60 to a high of $9.87. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. Mr. Schroeder is the trustee of this trust.
  4. This transaction was executed in multiple trades at prices ranging from a low of $9.68 to a high of $9.87. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.